www.klinickafarmakologie.cz / Klin Farmakol Farm. 2024;38(2):67-71 / KLINICKÁ FARMAKOLOGIE A FARMACIE 71 HLAVNÍ TÉMA Role farmakoterapie v léčbě amyotrofické laterální sklerózy 16. Hardiman O, van den Berg LH. Edaravone: a new treatment for ALS on the horizon? Lancet Neurol. 2017;16:490-491. 17. Witzel S, Maier A, Steinbach R, et al. Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2022;79:121-130. 18. Gao M, Zhu L, Chang J, et al. Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis. Clin Drug Investig. 2023;43:1-11. 19. Phase III study halted: Ferrer’s oral edaravone disappoints in ALS – Pharmaceutical Technology. https://www.pharmaceutical-technology.com/analyst-comment/phase-iii-study-halted-ferrer-oral-edaravone-disappoints-in-als/ (accessed 22 April 2024). 20. Van Damme P, Al-Chalabi A, Andersen PM, et al. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD). Eur J Neurol. 2024;e16264. 21. Paganoni S, Hendrix S, Dickson SP, et al. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle Nerve. 2021;63:31-39. 22. Morata-Tarifa C, Azkona G, Glass J, et al. Looking backward to move forward: a meta-analysis of stem cell therapy in amyotrophic lateral sclerosis. npj Regen Med. 2021;6:1-10. 23. Norris FH, U KS, Sachais B, et al. Trial of baclofen in amyotrophic lateral sclerosis. Arch Neurol. 1979;36:715-716. 24. Su Zhang VR, Niu F, Lee EA, et al. Safety of baclofen versus tizanidine for older adults with musculoskeletal pain. J Am Geriatr Soc. 2023;71:2579-2584. 25. Meyer T, Funke A, Münch C, et al. Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD). BMC Neurol. 2019;19:222. 26. AminiLari M, Wang L, Neumark S, et al. Medical cannabis and cannabinoids for impaired sleep: a systematic review and meta-analysis of randomized clinical trials. Sleep. 2022;45:zsab234. 27. Vázquez-Costa JF, Máñez I, Alabajos A, et al. Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study. J Neurol. 2016;263:1954-1960. 28. Garuti G, Rao F, Ribuffo V, et al. Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis. 2019;9:19-26. 29. Slade A, Stanic S. Managing excessive saliva with salivary gland irradiation in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 2015;352:34-36. 30. Garuti G, Rao F, Ribuffo V, et al. Sialorrhea in patients with ALS: current treatment options. Degener Neurol Neuromuscul Dis. 2019;9:19-26. 31. Miller TM, Layzer RB. Muscle cramps. Muscle & Nerve. 2005;32:431-442. 32. Garrison SR, Korownyk CS, Kolber MR, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. 2020;2020:CD009402.
RkJQdWJsaXNoZXIy NDA4Mjc=